BAGE5: Potential Drug Target and Biomarker (G85316)

Target Name: BAGE5

NCBI ID: G85316

BAGE5

BAGE5: Potential Drug Target and Biomarker

BAGE5 (BAGE5_HUMAN) is a protein that is expressed in human tissues and has been identified as a potential drug target or biomarker. BAGE5 is a key regulator of the cell cycle, and its levels have been shown to be elevated in various types of cancer.

Research has also shown that BAGE5 is involved in the regulation of cell survival, and that its levels can be used as a biomarker for cancer diagnosis and treatment. In addition, BAGE5 has been shown to play a role in the development and progression of various diseases , including neurodegenerative disorders, congestive lung disease and Alzheimer's disease, among others.

Recent studies have also shown that BAGE5 is involved in the regulation of cellular processes that are important for cancer growth and progression, such as cell adhesion, migration and invasion. These studies suggest that BAGE5 may be a useful drug target for the treatment of various types of cancer.

Additionally, BAGE5 has also been shown to be involved in the regulation of cellular processes that are important for aging and age-related diseases, such as Alzheimer's disease and cancer. This suggests that BAGE5 may be a useful biomarker for the early detection and treatment of these diseases.

Overall, BAGE5 is a protein that has been shown to be involved in a wide range of cellular processes that are important for human health and disease. As such, it has great potential as a drug target or biomarker for the treatment of various types of cancer and other diseases. Further research is needed to fully understand the role of BAGE5 in these processes and to develop effective treatments based on this protein.

Protein Name: BAGE Family Member 5

Functions: Unknown. Candidate gene encoding tumor antigens

The "BAGE5 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about BAGE5 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets